Peter Feinberg insider trades
Open-market stock purchases and sales by Peter Feinberg, Director at Immuneering Corp, from SEC Form 4 filings since Aug 3, 2021.
Track record: 40% of 15 scored buys are up 5% or more since purchase, averaging -7%.
Open-market stock purchases and sales by Peter Feinberg, Director at Immuneering Corp, from SEC Form 4 filings since Aug 3, 2021.
Track record: 40% of 15 scored buys are up 5% or more since purchase, averaging -7%.